These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

506 related articles for article (PubMed ID: 30563893)

  • 1. Early Loss of Histone H2B Monoubiquitylation Alters Chromatin Accessibility and Activates Key Immune Pathways That Facilitate Progression of Ovarian Cancer.
    Hooda J; Novak M; Salomon MP; Matsuba C; Ramos RI; MacDuffie E; Song M; Hirsch MS; Lester J; Parkash V; Karlan BY; Oren M; Hoon DS; Drapkin R
    Cancer Res; 2019 Feb; 79(4):760-772. PubMed ID: 30563893
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The RING finger domain E3 ubiquitin ligases BRCA1 and the RNF20/RNF40 complex in global loss of the chromatin mark histone H2B monoubiquitination (H2Bub1) in cell line models and primary high-grade serous ovarian cancer.
    Dickson KA; Cole AJ; Gill AJ; Clarkson A; Gard GB; Chou A; Kennedy CJ; Henderson BR; ; Fereday S; Traficante N; Alsop K; Bowtell DD; deFazio A; Clifton-Bligh R; Marsh DJ
    Hum Mol Genet; 2016 Dec; 25(24):5460-5471. PubMed ID: 27798111
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Loss of H2B monoubiquitination is associated with poor-differentiation and enhanced malignancy of lung adenocarcinoma.
    Zhang K; Wang J; Tong TR; Wu X; Nelson R; Yuan YC; Reno T; Liu Z; Yun X; Kim JY; Salgia R; Raz DJ
    Int J Cancer; 2017 Aug; 141(4):766-777. PubMed ID: 28481029
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Significance and expression of PAX8, PAX2, p53 and RAS in ovary and fallopian tubes to origin of ovarian high grade serous carcinoma].
    Mao YN; Zeng LX; Li YH; Liu YZ; Wu JY; Li L; Wang Q
    Zhonghua Fu Chan Ke Za Zhi; 2017 Oct; 52(10):687-696. PubMed ID: 29060967
    [No Abstract]   [Full Text] [Related]  

  • 5. Characterization of MicroRNA-200 pathway in ovarian cancer and serous intraepithelial carcinoma of fallopian tube.
    Yang J; Zhou Y; Ng SK; Huang KC; Ni X; Choi PW; Hasselblatt K; Muto MG; Welch WR; Berkowitz RS; Ng SW
    BMC Cancer; 2017 Jun; 17(1):422. PubMed ID: 28623900
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Chromosomal Instability and mTORC1 Activation through PTEN Loss Contribute to Proteotoxic Stress in Ovarian Carcinoma.
    Chui MH; Doodnauth SA; Erdmann N; Tiedemann RE; Sircoulomb F; Drapkin R; Shaw P; Rottapel R
    Cancer Res; 2019 Nov; 79(21):5536-5549. PubMed ID: 31530568
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Increased expression of neurotensin in high grade serous ovarian carcinoma with evidence of serous tubal intraepithelial carcinoma.
    Norris EJ; Zhang Q; Jones WD; DeStephanis D; Sutker AP; Livasy CA; Ganapathi RN; Tait DL; Ganapathi MK
    J Pathol; 2019 Jul; 248(3):352-362. PubMed ID: 30883751
    [TBL] [Abstract][Full Text] [Related]  

  • 8. let-7b and let-7c microRNAs promote histone H2B ubiquitylation and inhibit cell migration by targeting multiple components of the H2B deubiquitylation machinery.
    Spolverini A; Fuchs G; Bublik DR; Oren M
    Oncogene; 2017 Oct; 36(42):5819-5828. PubMed ID: 28604753
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Morphologic changes of fallopian tubal epithelium in ovarian serous tumors].
    Wen J; Shi JL; Shen DH; Chen YX; Song QJ
    Zhonghua Bing Li Xue Za Zhi; 2012 Jul; 41(7):433-7. PubMed ID: 22932451
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Stathmin 1 and p16(INK4A) are sensitive adjunct biomarkers for serous tubal intraepithelial carcinoma.
    Novak M; Lester J; Karst AM; Parkash V; Hirsch MS; Crum CP; Karlan BY; Drapkin R
    Gynecol Oncol; 2015 Oct; 139(1):104-11. PubMed ID: 26206555
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Histone H2B monoubiquitination regulates heart development via epigenetic control of cilia motility.
    Robson A; Makova SZ; Barish S; Zaidi S; Mehta S; Drozd J; Jin SC; Gelb BD; Seidman CE; Chung WK; Lifton RP; Khokha MK; Brueckner M
    Proc Natl Acad Sci U S A; 2019 Jul; 116(28):14049-14054. PubMed ID: 31235600
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Both fallopian tube and ovarian surface epithelium are cells-of-origin for high-grade serous ovarian carcinoma.
    Zhang S; Dolgalev I; Zhang T; Ran H; Levine DA; Neel BG
    Nat Commun; 2019 Nov; 10(1):5367. PubMed ID: 31772167
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Genomics of Ovarian Cancer Progression Reveals Diverse Metastatic Trajectories Including Intraepithelial Metastasis to the Fallopian Tube.
    Eckert MA; Pan S; Hernandez KM; Loth RM; Andrade J; Volchenboum SL; Faber P; Montag A; Lastra R; Peter ME; Yamada SD; Lengyel E
    Cancer Discov; 2016 Dec; 6(12):1342-1351. PubMed ID: 27856443
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Genomic landscape and evolutionary trajectories of ovarian cancer precursor lesions.
    Wu RC; Wang P; Lin SF; Zhang M; Song Q; Chu T; Wang BG; Kurman RJ; Vang R; Kinzler K; Tomasetti C; Jiao Y; Shih IM; Wang TL
    J Pathol; 2019 May; 248(1):41-50. PubMed ID: 30560554
    [TBL] [Abstract][Full Text] [Related]  

  • 15. NF-κB-miR-155 axis activation mediates ovulation-induced oncogenic effects in fallopian tube epithelium.
    Brand H; Barnabas GD; Sapoznik S; Bahar-Shany K; Pozniak Y; Yung Y; Hourvitz A; Geiger T; Jacob-Hirsch J; Levanon K
    Carcinogenesis; 2020 Dec; 41(12):1703-1712. PubMed ID: 32614381
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Gene expression profiles of ovarian low-grade serous carcinoma resemble those of fallopian tube epithelium.
    Qiu C; Lu N; Wang X; Zhang Q; Yuan C; Yan S; Dongol S; Li Y; Sun X; Sun C; Zhang Z; Zheng W; Kong B
    Gynecol Oncol; 2017 Dec; 147(3):634-641. PubMed ID: 28965696
    [TBL] [Abstract][Full Text] [Related]  

  • 17. RNF20 and histone H2B ubiquitylation exert opposing effects in Basal-Like versus luminal breast cancer.
    Tarcic O; Granit RZ; Pateras IS; Masury H; Maly B; Zwang Y; Yarden Y; Gorgoulis VG; Pikarsky E; Ben-Porath I; Oren M
    Cell Death Differ; 2017 Apr; 24(4):694-704. PubMed ID: 28157208
    [TBL] [Abstract][Full Text] [Related]  

  • 18. p53 signature and serous tubal in-situ carcinoma in cases of primary tubal and peritoneal carcinomas and serous borderline tumors of the ovary.
    Leonhardt K; Einenkel J; Sohr S; Engeland K; Horn LC
    Int J Gynecol Pathol; 2011 Sep; 30(5):417-24. PubMed ID: 21804388
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Activin A stimulates migration of the fallopian tube epithelium, an origin of high-grade serous ovarian cancer, through non-canonical signaling.
    Dean M; Davis DA; Burdette JE
    Cancer Lett; 2017 Apr; 391():114-124. PubMed ID: 28115208
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The tubal epigenome - An emerging target for ovarian cancer.
    Reavis HD; Drapkin R
    Pharmacol Ther; 2020 Jun; 210():107524. PubMed ID: 32197795
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 26.